The great minds of today are shaping innovation and the future. An entrepreneur that is known for his contributions to the global community is Eric Lefkosky, a U.S. business man and inventor. Lefkosky is known for several endeavors developed as a serial entrepreneur, each which have offered cutting edge changes to the globe while providing new solutions to those interested in technology, health and business and more information click here.
Lefkofsky began as an entrepreneur in 1993 through an apparel brand, beginning his first business quickly after college. While the apparel did not reach a level of success, it led Lefkofsky to his second business of Starbelly, which offered marketing solutions for the Internet. While Starbelly was known for it’s early success on the web, it quickly went bankrupt and was unable to continue with the Internet offerings.
The early lessons of Lefkofsky led to different approaches to business that has led to his success. His latest development is Tempus, which offers an innovative technology to offer personalized cancer care. The new company launched in 2016 and Lefkofsky is continuing to provide a position as a CEO. He also serves as co-founder and CEO of Groupon, the online coupon site that has developed a global reputation for the services provided. Lefkofsky has also developed a media company, venture capital fund and analytics company, all which have led to success for the entrepreneur.
The many endeavors of Lefkofskt has not only created a legend of his entrepreneurial spirit. This has led to other opportunities for the community. Lefkosfky is known for his charitable foundation, designed to support the global community through education, science and children. He is also known among community organizations for his concepts about disruptive business models and the entrepreneurial spirit and Eric’s lacrosse camp.
The businesses and contributions of Eric Lefkosfky have provided diverse options for the community. From his most recent contribution of Tempus to his commitment to charities and businesses, he has provided several ideals for technology, innovation and positive disruption. Through his many successes in business, Lefkosky has become a part of the new frontier for technology and the entreprenurial spirit and learn more about Eric.
Other Reference: http://lefkofskyfoundation.com/about-eric-lefkofsky/
Cancer treatment is a very complicated and expensive process that requires costly and sophisticated equipment. Eric Lefkofsky is the Chief Executive Officer of Tempus which is a technological company that has built an operating machine that helps in the battle against cancer. The company has announced that it will be using data to help in the treatment of cancer patients. Tempus has partnered with the University of Chicago Medicine to supply them with information from over 1000 breast cancer patients to help doctor and medical researcher develop a suitable treatment plan. With the provision of this vital data, doctors will be able to monitor the trends in infection and work towards finding a proper remedy to many people living with breast cancer. Most of the time, doctors treat breast cancer without actually following the pattern and finding out what the possible cause of increased infections. This makes it difficult to fight the disease that keeps on affecting many people especially women. Breast cancer is one of the most common types of cancer and has been claiming the lives of individuals globally.
Tempus has invested in sophisticated machines with genomic sequencing that enables the doctors to make a real-time diagnosis and make treatment easy. Tempus was established in 2015 and has been making tremendous progress in the treatment of cancer. The company is headquartered in Chicago and has partnered with many other research centers like Robert H. Lurie Comprehensive Cancer Center of Northwestern University, the University of Michigan, and the Mayo Clinic among other that have incorporated data in finding a cure to the cancer epidemic and Eric of Twitter.
Eric Lefkofsky has a long career history in establishing some of the most successful technological companies across the US. He is the founding member of Lightbank that has invested in the disruptive technological field. He is the founder of Groupon; this is one of the largest e-commerce operated marketplaces with increased strings of customers. Eric Lefkofsky has also diversified and contributes towards the philanthropic world. He has partnered with his wife to uplift the communities living within his firm. He also provides employment opportunities to people within his community area with the aim of improving their living standards.
Oncotarget, a medical journal, was first published in 2010 by Impact Journals. It is a weekly journal that covers all fields of medical science, not only and Oncology but also Cardiology, Neuroscience etc.The Editor in chief is Mikhail Blagosklonny with Andrei V. Gudkov, who are both prominent scientists from Roswell Park Cancer Institute.
Oncotarget is a journal provides access for free to users around the world. Weekly issues of papers are available online from Oncotarget, and they can be read by anyone that is looking to educate themselves about diseases and scientific results. Papers can be used online, or they can be printed in hard copy format. Oncotarget’s mission is to make sure that scientific results are readily available for the public, which enables Oncotarget to enhance research capabilities. Under scientific leadership, Oncotarget has been able assist with solving cures for diseases. Oncotarget, which is published by Impact Journals
Mikhail Blagosklonny is a professor of Oncology at this Institute and well-known for his hypothesis about extending life span using rapamycin (anti-cancer drug). Apart from many entitlements, Andrei V. Gudkov is also known as an author of more than 100 publications.
The main goal that competent authors of this medical journal want to achieve is that the all newest studies become quickly available to all their readers.
Also, it is worth to mention that this journal attempts to overcome the gap between different specialities by gathering researchers from all fields of medicine in one place. The main cause of this concept is to encourage more studies to be done in order to fight deadly diseases and give humanity a hope. Oncotarget is also available on Dove Press.